Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) dropped 14.7% on Wednesday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The company has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a 50 day moving average price of C$0.11 and a 200-day moving average price of C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is Insider Trading? What You Can Learn from Insider Trading
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
